000453572_sm_Erratum.PDF (26.97 kB)
Erratum: HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature
dataset
posted on 2017-07-25, 14:09 authored by Gevorgyan A., Bregni G., Galli G., Zanardi E., de Braud F., Di Cosimo S.Background: Neuroendocrine carcinoma is an uncommon histology for breast cancer. Case Report: Our patient underwent right quadrantectomy for a neuroendocrine carcinoma in 1984 and had a bone relapse 30 years later. After thorough pathological and immunohistochemical analysis the diagnosis was confirmed and HER2 amplification was observed. Here we discuss the management, rationale and results of HER2-targeted therapy in advanced neuroendocrine breast carcinoma.